# Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

> **NCT00099684** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT00099684
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099684, "Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00099684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*